Cruz Cobalt Engages Precision GeoSurveys for BC Cobalt Work Program
Jan 08, 2018 12:26 pm UTC| Business
VANCOUVER, British Columbia, Jan. 08, 2018 -- Cruz Cobalt Corp. (CUZ—TSXv, BKTPF—OTCBB, A2DMG8--FSE) Cruz Cobalt Corp. ("Cruz" or the "Company") is pleased to announce that it has secured the services of Precision...
Jan 08, 2018 12:26 pm UTC| Business
FOR IMMEDIATE RELEASE REGULATED INFORMATION - INSIDE INFORMATION GHENT, Belgium, 8 January 2018 - Ablynx NV (Euronext Brussels and Nasdaq: ABLX) ("Ablynx" or the "Company") today confirmed that on December 22,...
Jan 08, 2018 12:20 pm UTC| Business
PUNE, India, Jan. 08, 2018 -- The global oil and gas storage service market was valued at $8.42 billion in 2016, and is projected to reach $10.38 billion by 2022, growing at a CAGR of 2.6% from 2017 to 2024. In 2016,...
Jan 08, 2018 12:15 pm UTC| Business
· CA4P and checkpoint inhibitor combination nearly doubles amount of tumor necrosis SOUTH SAN FRANCISCO, Calif., Jan. 08, 2018 -- Mateon Therapeutics, Inc. (OTCQX:MATN), a biopharmaceutical company developing...
Jan 08, 2018 12:08 pm UTC| Business
Dublin, Jan. 08, 2018 -- The "Drug Discovery Informatics Market by Function, Solution and End User - Global Forecast to 2022" report has been added to Research and Markets' offering. The global drug...
Jan 08, 2018 12:05 pm UTC| Business
-- Increases KRYSTEXXA® (pegloticase injection) Estimated Peak Annual Net Sales to more than $750 Million ---- Increases Teprotumumab Estimated Peak Annual Net Sales to more than $750 Million ---- Confirms Expectation of...
Jan 08, 2018 12:02 pm UTC| Business
Press ReleaseSource: Sanofi (EURONEXT: SAN) (NYSE: SNY) Sanofi and Regeneron to accelerate and expand investment for cemiplimab and dupilumab development programs Companies also announce submission of dupilumab...